论文部分内容阅读
目的观察和研究参松养心胶囊治疗慢性肺源性心脏病心律失常的疗效。方法对100例慢性肺源性心脏病心律失常患者,并将患者随机分成治疗组和对照组各50例,对照组只进行西医常规治疗;治疗组除进行西医常规治疗外,还口服参松养心胶囊,1次4粒,1d3次,治疗4周后,用动态心电图、24h心电监护结果及临床症状来综合评价各自的治疗效果。结果治疗组和对照组的治疗总有效率分别为94.0%和86.0%,两组之间差异有统计学意义(P<0.05)。结论参松养心胶囊对慢性肺源性心脏病心律失常疗效较好,值得在临床推广。
Objective To observe and study the effect of Shensong Yangxin Capsule in treating arrhythmia of chronic cor pulmonale. Methods A total of 100 patients with chronic cor pulmonale of cardiac arrhythmia were randomly divided into treatment group (n = 50) and control group (n = 50), and control group (n = 50) were treated with routine Western medicine only. Heart capsule, a 4, 1d3 times, after 4 weeks of treatment, with the dynamic electrocardiogram, 24h ECG monitoring results and clinical symptoms to evaluate their respective effects. Results The total effective rates of the treatment group and the control group were 94.0% and 86.0%, respectively. There was significant difference between the two groups (P <0.05). Conclusion Shensong Yangxin Capsule has a good curative effect on arrhythmia of chronic cor pulmonale, which is worthy of clinical promotion.